Ongoing research is exploring new molecular targets and targeted therapies for this challenging disease.

Cobimetinib fumarate is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Fallopian Tube Cancer.

A 50-year-old man was diagnosed with leprosy on pre-immigration screening in the Philippines and was prescribed oral dapsone and rifampin. He immigrated to Canada 1 month later and discontinued ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced long-term overall survival (OS) data ...

A 57-year-old woman with no known comorbidities presented to our dermatology clinic with a 6-month history of asymptomatic lesions on her upper back and upper limbs. Examination revealed well-defined, ...

Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma who are candidates for systemic therapy, ...

Dermatitis. 2005;16(3):115-120.

Detailed results from the TROPION-Lung01 Phase III trial showed a clinically meaningful trend toward improving overall survival (OS) with datopotamab ...

Orazi, A and Germing, U 2008. The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features. Leukemia, Vol. 22, Issue. 7, p ...

In all controls, IRS for the antisense strand of the orf1ab gene was 0. Figure 6. Evidence of marked chronic histiocytic intervillositis. Representative images of case 2i with stillbirth at 30 weeks ...